The race will be on—a year from September—to unlock the full DNA code of 100 centenarians, in 30 days, for no more than $1,000 per genome. The prize: $10 million and, perhaps, the fountain of youth. Scientists believe those who live to an old age may have rare changes in their genes which protect them from diseases. Identifying the genes could lead to ways to prolong life. The catch is that a very large pool of people will need to be tested to steer scientists in the right direction. Hence, the competition to spur companies to develop technology that can rapidly—and cheaply—sequence the human genome. The first mapping of the human genome was completed in 2003 after 13 years and cost billions. Today, mapping the human genome is estimated to cost around $3,000 and take a week.
The Illinois carrier recently raised $35 million through a stock offering.
One of the recorded votes on amendments was on a jab at short-term health insurance.
The policy will offer the insureds access to the SilverSneakers and WholeHealth Living Choices programs.
Sponsored by Fidelity Investments
Get insights into the mindset that’s driving today’s advisors to make a move--and help realize their unique business vision.
Don’t miss crucial news and insights you need to make informed investment advisory decisions. Join ThinkAdvisor.com now!
- Free unlimited access to ThinkAdvisor.com which provides advisors, like you, with comprehensive coverage of the products, services and trends necessary to guide your clients in making critical wealth, health and life decisions.
- Exclusive discounts on ALM and ThinkAdvisor events.
- Access to other award-winning ALM websites including TreasuryandRisk.com and Law.com.
Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.